title: Questions and answers on proper peri-operative management of antiplatelet therapy after coronary stent implantation to prevent stent thrombosis.
abstract: Stent thrombosis (ST) is a rare but life-threatening complication of coronary artery stenting. Although dual-antiplatelet therapy is an effective management strategy in reducing the risk for ST, some patients may need to interrupt their regimens because of unforeseen circumstances, such as the requirement for surgery. In conclusion, this case presentation highlights some pertinent issues related to ST, including its risk factors, the perioperative management of antiplatelet agents, and treatment for ST.
authors.affiliation: Division of Cardiovascular Disease, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
authors.forename: Ammar M
authors.initials: AM
authors.lastname: Killu
authors.forename: R Scott
authors.initials: RS
authors.lastname: Wright
authors.forename: Stephen L
authors.initials: SL
authors.lastname: Kopecky
mesh_terms: D000368:Aged; D003328:Coronary Thrombosis / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D004868:Equipment Failure; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000628:therapy*; D019990:Perioperative Care / Q000379:methods*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors